Invocare – Add to Watchlist

InvoCare comes onto our watchlist following the 1H19 result which showed 10% revenue growth and NPAT up 9%.

The stock is nearing our entry-level following recent retracement in price.

You’re not a member!  Trial today

Look for the next Algo Engine buy signal.

 

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.